speb/financial-data huggingface dataset:
Stock screener scorecard for WIMI (annual, report date 2025-12-31)
Altman Z-score: 0.8394213079177442 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.336638960095437%
Capitalized R&D asset: 27230202.53227724
ROCI (R&D adjusted): -2.5524053982186636%
Rosenberg metric: -0.36119652454052914
Free cash flow margin: 8.744223391926926%
Revenue growth: -18.744858932465437%
Rule of 40 score: -10.00063554053851
Market cap: 21142812 (Nano Cap (< $50M))
P/E ratio: 1.0085106382978724
Debt to equity: 0.0894
Free cash flow (dilution adjusted): 5274583.142857142
Operating income: -3400513.4285714286
Net income: 49588000.28571428
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for YHNA (quarterly, report date 2026-03-31)
Altman Z-score: 85.34369925713526 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.3829683418661375%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.5385819959127979%
Rule of 40 score: 0
Market cap: 46801164 (Nano Cap (< $50M))
P/E ratio: 82.46153846153847
Debt to equity: 0
Free cash flow (dilution adjusted): -24189.79591836735
Operating income: -18173.214285714286
Net income: 12189.66836734694
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for ZGL.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25869600 (Nano Cap (< $50M))
P/E ratio: 1.4705882352941175
Debt to equity: 0.2887
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0704.HK (annual, report date 2025-03-31)
Altman Z-score: -1.1835183550405113 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.2003146351055944%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.462677931362502%
Free cash flow margin: 2.1793748174116274%
Revenue growth: 1333.6241009791745%
Rule of 40 score: 1335.803475796586
Market cap: 26133591.15 (Nano Cap (< $50M))
Debt to equity: 0.21087217510732914
Free cash flow (dilution adjusted): 95886.88946015424
Operating income: -2300514.1388174808
Net income: -3789717.2236503856
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1655.HK (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1723192880.1538856 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2371.HK (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 289119159 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2499.T (annual, report date 2025-12-31)
Altman Z-score: 2.183392110228042 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.659878183950843%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.282978879879351%
Free cash flow margin: 8.480758985196134%
Revenue growth: -4.298387737095067%
Rule of 40 score: 4.1823712481010675
Market cap: 3225448830.334466 (Mid Cap ($2B-$10B))
P/E ratio: 13.948369372062453
Debt to equity: 1.0948281174064447
Free cash flow (dilution adjusted): 2432363.659612557
Operating income: 2399609.999360655
Net income: 1478434.8826801355
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 3708.HK (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 109091999.99999999 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7073.T (annual, report date 2026-01-31)
Altman Z-score: 2.967850275301354 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 46.94168022198833%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.016308618947543%
Free cash flow margin: 6.525692272735093%
Revenue growth: 7.470958185455983%
Rule of 40 score: 13.996650458191075
Market cap: 2252289792 (Mid Cap ($2B-$10B))
P/E ratio: 17.321708506694762
Debt to equity: 1.1257500952352215
Free cash flow (dilution adjusted): 1907005.7456254896
Operating income: 1328114.3901802038
Net income: 848961.8699399321
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for AASB.OL (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.463037898165314%
Capitalized R&D asset: 0
Free cash flow margin: -52.213704552505426%
Revenue growth: 17.124243152424437%
Rule of 40 score: -35.08946140008099
Market cap: 225993666.60000005 (Micro Cap ($50M-$300M))
P/E ratio: 2.7583750347857934
Debt to equity: 1.3926921636825411
Free cash flow (dilution adjusted): -10382786.06965174
Net income: 8152238.805970149
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ALCO (annual, report date 2025-09-30)
Altman Z-score: -0.487229736150244 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -104.14589547664774%
Free cash flow margin: 31.514092497617213%
Revenue growth: -5.524944793430954%
Rule of 40 score: 25.98914770418626
Market cap: 256085771.31 (Micro Cap ($50M-$300M))
Debt to equity: 0.7921458599551827
Free cash flow (dilution adjusted): 13887000
Operating income: -203901000
Net income: -147334000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ALCOG.PA (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16984770 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARL (annual, report date 2025-12-31)
Altman Z-score: 1.6205681638067178 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.049044061910839%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6158724380559162%
Free cash flow margin: -11.10289119046667%
Revenue growth: 5.697620355889936%
Rule of 40 score: -5.405270834576734
Market cap: 259401810.57999998 (Micro Cap ($50M-$300M))
P/E ratio: 13.992222373375046
Debt to equity: 0.26151023450490224
Free cash flow (dilution adjusted): -5553000
Operating income: -6429000
Net income: 18539000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AXIN (annual, report date 2025-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 153354640 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BAC (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.013628096421343%
Capitalized R&D asset: 0
Free cash flow margin: 7.614702423583296%
Revenue growth: 6.840424727932286%
Rule of 40 score: 14.455127151515581
Market cap: 388112542703.19 (Mega Cap (>= $200B))
P/E ratio: 12.721247589340521
Debt to equity: 1.2066362620076967
Free cash flow (dilution adjusted): 8612000000
Net income: 30509000000
Long score: 3 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CADL (annual, report date 2025-12-31)
Altman Z-score: 0.6209477835913657 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -72.98832864681638%
Capitalized R&D asset: 51523360
ROCI (R&D adjusted): -25.311623993509237%
Rule of 40 score: 0
Market cap: 413976850.35 (Small Cap ($300M-$2B))
Debt to equity: 0.9443781056199684
Free cash flow (dilution adjusted): -42715000
Operating income: -48177000
Net income: -38182000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CBRE (annual, report date 2025-12-31)
Altman Z-score: 3.2759184404536694 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -143.23144104803492%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.973109877674193%
Free cash flow margin: 2.6461159062885327%
Revenue growth: 13.372661950960381%
Rule of 40 score: 16.018777857248914
Market cap: 47081977737.409996 (Large Cap ($10B-$200B))
P/E ratio: 36.86920731198904
Debt to equity: 1.0379181383752338
Free cash flow (dilution adjusted): 1073000000
Operating income: 1294000000
Net income: 1277000000
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTA.V (annual, report date 2025-12-31)
Altman Z-score: -25.148705263398 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.0051331408405515%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.078372268274304%
Free cash flow margin: -6290%
Revenue growth: 73.96593673965936%
Rule of 40 score: -6216.03406326034
Market cap: 2155087.35 (Nano Cap (< $50M))
P/E ratio: 17.2406988
Debt to equity: 0.6016578749058026
Free cash flow (dilution adjusted): -459124.0875912408
Operating income: -391240.87591240875
Net income: 91240.87591240875
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for GHRS (annual, report date 2025-12-31)
Altman Z-score: 51.82541415608362 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -17.176791096269973%
Capitalized R&D asset: 80978499.01960786
ROCI (R&D adjusted): -15.64617208515226%
Rule of 40 score: 0
Market cap: 740633280.6049999 (Small Cap ($300M-$2B))
Debt to equity: 0.0018305130799455137
Free cash flow (dilution adjusted): -61384705.88235294
Operating income: -71383529.41176471
Net income: -56774117.64705882
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for IMRN (annual, report date 2025-06-30)
Altman Z-score: -5.2103026648612145 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -64.026072445906%
Capitalized R&D asset: 5318708.36777648
ROCI (R&D adjusted): -34.731576249780765%
Rosenberg metric: 0.24832636424569157
Free cash flow margin: -84.21774825916062%
Revenue growth: 45.713161750183566%
Rule of 40 score: -38.50458650897705
Market cap: 21487153.9644 (Nano Cap (< $50M))
Debt to equity: 0.008905008083350529
Free cash flow (dilution adjusted): -4011077.7777777775
Operating income: -3501131.3725490198
Net income: -3409141.8300653594
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for JLP.L (annual, report date 2025-06-30)
Altman Z-score: -0.004132954366436903 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.532967513640655%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.961116568402977%
Free cash flow margin: -136.83776799282748%
Revenue growth: -11.16805225731042%
Rule of 40 score: -148.0058202501379
Market cap: 969252.345 (Nano Cap (< $50M))
Debt to equity: 0.08332624830103123
Free cash flow (dilution adjusted): -28446671.23287671
Operating income: -35058264.38356164
Net income: -40767694.52054795
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for NPB (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.207791004594165%
Capitalized R&D asset: 0
Free cash flow margin: 17.056995933294445%
Revenue growth: 29.16617683207045%
Rule of 40 score: 46.22317276536489
Market cap: 578554216.66 (Small Cap ($300M-$2B))
P/E ratio: 6.936352391948112
Debt to equity: 2.7000028117432455
Free cash flow (dilution adjusted): 41230000
Net income: 83409000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PDL.L (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 531961.1595000001 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PROV (annual, report date 2025-06-30)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.165584036718658%
Capitalized R&D asset: 0
Free cash flow margin: 19.51794871794872%
Revenue growth: 0.3499382461918485%
Rule of 40 score: 19.867886964140567
Market cap: 93617754.27000001 (Micro Cap ($50M-$300M))
P/E ratio: 14.966867189448442
Debt to equity: 1.657575168229025
Free cash flow (dilution adjusted): 7612000
Net income: 6255000
Long score: 3 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for RMM (annual, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.426242616134963%
Capitalized R&D asset: 0
Revenue growth: -524.4977901965358%
Rule of 40 score: -524.4977901965358
Market cap: 245758368.6 (Micro Cap ($50M-$300M))
Debt to equity: 0.6426828665801109
Free cash flow (dilution adjusted): 36885900
Net income: -12858278
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SABA.V (annual, report date 2024-12-31)
Altman Z-score: 0.4061987323663978 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.41427397866101%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.62269871527996%
Free cash flow margin: -4.980122855794251%
Rule of 40 score: -4.980122855794251
Market cap: 11150985.440000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -168075.5244755245
Operating income: -1544068.5314685316
Net income: -1471706.2937062937
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for SPI.V (annual, report date 2025-06-30)
Altman Z-score: -13.928249765197242 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -202.44785362177805%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -18.500819311718626%
Free cash flow margin: -2292.3118646169105%
Revenue growth: -78.03758198297545%
Rule of 40 score: -2370.349446599886
Market cap: 5763551.66 (Nano Cap (< $50M))
Debt to equity: 0.0018683793181920817
Free cash flow (dilution adjusted): -1079695.6204379562
Operating income: -1542672.9927007298
Net income: -13598372.262773722
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TBBB (annual, report date 2025-12-31)
Altman Z-score: 2.931461402161454 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -109.52661719722747%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.524490901801802%
Free cash flow margin: -2.331230187966178%
Revenue growth: 56.1161611063261%
Rule of 40 score: 53.784930918359926
Market cap: 46790396249.5368 (Large Cap ($10B-$200B))
Debt to equity: 3.388588543311696
Free cash flow (dilution adjusted): -101330645.16129032
Operating income: -37554505.00556173
Net income: -157929421.5795328
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for VBNK (annual, report date 2025-10-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.003193334013322%
Capitalized R&D asset: 0
Free cash flow margin: 34.83283991623944%
Revenue growth: 10.854950725016032%
Rule of 40 score: 45.687790641255475
Market cap: 534126613.22999996 (Small Cap ($300M-$2B))
P/E ratio: 18.7689441714105
Debt to equity: 0.20371222119386573
Free cash flow (dilution adjusted): 31011428.571428575
Net income: 20327142.85714286
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for VVC.V (annual, report date 2025-01-31)
Altman Z-score: -2.5020053066188783 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.434319116427492%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -22.357745372402533%
Free cash flow margin: -3787.7876897692317%
Revenue growth: 295.38799644183985%
Rule of 40 score: -3492.399693327392
Market cap: 17180454.45 (Nano Cap (< $50M))
Debt to equity: 0.08805521188028927
Free cash flow (dilution adjusted): -3388032.413793104
Operating income: -4109575.1724137934
Net income: -2760144.1379310344
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for YHNA (annual, report date 2025-12-31)
Altman Z-score: 90.21163128329317 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.330593315060734%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.313180669088004%
Rule of 40 score: 0
Market cap: 353776523.10179996 (Small Cap ($300M-$2B))
P/E ratio: 266.97757488719867
Debt to equity: 0
Free cash flow (dilution adjusted): -142503.72750642675
Operating income: -146130.9768637532
Net income: 170323.52185089973
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 0029.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2372282624 (Mid Cap ($2B-$10B))
Debt to equity: 0.0003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0146.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 318281216 (Small Cap ($300M-$2B))
P/E ratio: 1.1889460154241644
Debt to equity: 0.25579999999999997
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0213.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 328345568 (Small Cap ($300M-$2B))
P/E ratio: 1.0282776349614395
Debt to equity: 1.2235
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0254.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 114879680 (Micro Cap ($50M-$300M))
Debt to equity: 3.9163
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0357.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2138922752 (Mid Cap ($2B-$10B))
Debt to equity: 0.9727
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0357.HK (annual, report date 2025-12-31)
Altman Z-score: 0.27793433163507736 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -13.415971207350788%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.771884304433945%
Free cash flow margin: 16.847400714466392%
Revenue growth: -3.6042544653358566%
Rule of 40 score: 13.243146249130536
Market cap: 2138922752 (Mid Cap ($2B-$10B))
Debt to equity: 0.9727
Free cash flow (dilution adjusted): 48297583.571428575
Operating income: -34861154.428571425
Net income: -39222469
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for 0771.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 587600640 (Small Cap ($300M-$2B))
P/E ratio: 0.8740359897172236
Debt to equity: 0.0113
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0771.HK (annual, report date 2025-12-31)
Altman Z-score: 1.5432859022681118 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.24162280772712%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.906957544120017%
Free cash flow margin: -3.333238657953461%
Revenue growth: 9.512120183636194%
Rule of 40 score: 6.1788815256827325
Market cap: 587600640 (Small Cap ($300M-$2B))
P/E ratio: 0.8740359897172236
Debt to equity: 0.0113
Free cash flow (dilution adjusted): -11162467.866323907
Operating income: 9390874.035989717
Net income: 10589845.758354755
Long score: 2 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for 0788.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 167819526144 (Large Cap ($10B-$200B))
P/E ratio: 1.7095149748210972
Debt to equity: 0.441
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0834.HK (annual, report date 2025-12-31)
Altman Z-score: 1.6294029267545649 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.36949483663782%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.2723789086450026%
Free cash flow margin: -2.1321467972301478%
Revenue growth: 17.35051689249455%
Rule of 40 score: 15.218370095264403
Market cap: 131354920 (Micro Cap ($50M-$300M))
Debt to equity: 0.7156999999999999
Free cash flow (dilution adjusted): -5657142.857142857
Operating income: -2117857.1428571427
Net income: -2435714.285714286
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for 0834.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 131354920 (Micro Cap ($50M-$300M))
Debt to equity: 0.7156999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1156.HK (annual, report date 2025-12-31)
Altman Z-score: -0.635739353654025 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1356809.0019569471
Rosenberg metric: -0.2634826082331672
Free cash flow margin: 7.406157248443228%
Revenue growth: 4.880216590077531%
Rule of 40 score: 12.28637383852076
Market cap: 215851760 (Micro Cap ($50M-$300M))
Debt to equity: -1.7871184088806666
Free cash flow (dilution adjusted): 909000
Operating income: -1425857.142857143
Net income: -3771285.714285714
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1156.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 215851760 (Micro Cap ($50M-$300M))
Debt to equity: -1.7871184088806666
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2002.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 572929802240 (Mega Cap (>= $200B))
P/E ratio: 0.1157001587237224
Debt to equity: 0.17
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2294.T (quarterly, report date 2026-04-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24854605824 (Large Cap ($10B-$200B))
P/E ratio: 0.198210818975225
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2509.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3618581248 (Mid Cap ($2B-$10B))
P/E ratio: 1.5061428548898388
Debt to equity: 0.8541
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2509.HK (annual, report date 2025-12-31)
Altman Z-score: 1.2697747334226108 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 50.481788513304274%
Capitalized R&D asset: 83760912.20243257
ROCI (R&D adjusted): -25.941795737312397%
Rosenberg metric: -0.26869759661512543
Free cash flow margin: 362.2176573482229%
Revenue growth: -37.724610524033544%
Rule of 40 score: 324.4930468241893
Market cap: 3618581248 (Mid Cap ($2B-$10B))
P/E ratio: 1.5061428548898388
Debt to equity: 0.8541
Free cash flow (dilution adjusted): 49067571.42857143
Operating income: -54131852.94571429
Net income: 44921428.571428575
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2651.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 974658112 (Small Cap ($300M-$2B))
P/E ratio: 1.6796359341346487
Debt to equity: 0.2
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3089.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1818619520 (Small Cap ($300M-$2B))
P/E ratio: 0.03534190937508778
Debt to equity: 0.0004
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 477A.T (annual, report date 2026-03-31)
Altman Z-score: 1.3295714619617094 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.36893296981119%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.816042674647436%
Free cash flow margin: -13.225385364532908%
Revenue growth: 17.228363087032434%
Rule of 40 score: 4.002977722499526
Market cap: 2482731008 (Mid Cap ($2B-$10B))
P/E ratio: 0.02171424180407439
Debt to equity: 2.417077571933889
Free cash flow (dilution adjusted): -4632839.089089089
Operating income: 2819456.956956957
Net income: 2711373.8738738736
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 477A.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2482731008 (Mid Cap ($2B-$10B))
P/E ratio: 0.02171424180407439
Debt to equity: 2.417077571933889
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4S0.DE (quarterly, report date 2026-06-30)
Altman Z-score: 3.035582834459802 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -53.62976406533575%
Capitalized R&D asset: 1721500000
ROCI (R&D adjusted): 1.13023617226683%
Rosenberg metric: -0.014580801944106925
Free cash flow margin: -4.489591171306747%
Revenue growth: 5.755968169761274%
Rule of 40 score: 1.2663769984545263
Market cap: 88250466304 (Large Cap ($10B-$200B))
P/E ratio: 69.1972920696325
Debt to equity: 0.6754000000000001
Free cash flow (dilution adjusted): -179000000
Operating income: 162000000
Net income: 298000000
Long score: 3 | Short score: 11
Recommendation: Short
Stock screener scorecard for 6042.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7248088064 (Mid Cap ($2B-$10B))
P/E ratio: 0.05529797465344417
Debt to equity: 0.5791
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6042.T (annual, report date 2026-03-31)
Altman Z-score: 1.8324604781041334 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.453579828679283%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.034748583938789%
Free cash flow margin: -28.901555375674327%
Revenue growth: 3.782442674829465%
Rule of 40 score: -25.119112700844862
Market cap: 7248088064 (Mid Cap ($2B-$10B))
P/E ratio: 0.05529797465344417
Debt to equity: 0.5791
Free cash flow (dilution adjusted): -16759934.934934935
Operating income: 6916572.822822822
Net income: 5977852.852852853
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 6255.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12171355136 (Large Cap ($10B-$200B))
P/E ratio: 0.14437773925847033
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6588.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 162936881152 (Large Cap ($10B-$200B))
Debt to equity: 0.44659999999999994
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6637.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 49978552320 (Large Cap ($10B-$200B))
P/E ratio: 0.0717855729788904
Debt to equity: 0.1142
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6886.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.1914372534494335%
Capitalized R&D asset: 0
Free cash flow margin: 367.43049428066746%
Revenue growth: 18.691096693961992%
Rule of 40 score: 386.12159097462944
Market cap: 153998295040 (Large Cap ($10B-$200B))
P/E ratio: 0.8548884670147129
Debt to equity: 2.494
Free cash flow (dilution adjusted): 5163157949.976845
Net income: 696151092.0940665
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7218.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10075700224 (Large Cap ($10B-$200B))
P/E ratio: 0.05512299261791256
Debt to equity: 0.2032
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7276.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 645947260928 (Mega Cap (>= $200B))
P/E ratio: 0.2531355177340579
Debt to equity: 0.0028000000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7481.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 21125038080 (Large Cap ($10B-$200B))
P/E ratio: 0.04624261786547804
Debt to equity: 0.0177
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7769.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30811578368 (Large Cap ($10B-$200B))
P/E ratio: 0.07604937622650261
Debt to equity: 0.2422
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7883.T (annual, report date 2026-03-31)
Altman Z-score: 1.9516274736127162 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.462919029060815%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.8761623211428646%
Free cash flow margin: 2.998018494633824%
Revenue growth: -2.4385493370634657%
Rule of 40 score: 0.5594691575703585
Market cap: 6073288704 (Mid Cap ($2B-$10B))
P/E ratio: 0.07631119022248055
Debt to equity: 0.1008
Free cash flow (dilution adjusted): 3213138.138138138
Operating income: 2031637.887887888
Net income: 2883746.246246246
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7883.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6073288704 (Mid Cap ($2B-$10B))
P/E ratio: 0.07631119022248055
Debt to equity: 0.1008
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7902.T (annual, report date 2026-03-31)
Altman Z-score: 4.2903437496413215 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.367138860304781%
Capitalized R&D asset: 1683474.5772366999
ROCI (R&D adjusted): 3.4062293764324605%
Rosenberg metric: 0.5136292466571001
Free cash flow margin: 9.827807949077776%
Revenue growth: 4.798482327784486%
Rule of 40 score: 14.626290276862262
Market cap: 3925777408 (Mid Cap ($2B-$10B))
P/E ratio: 0.07890369767833041
Debt to equity: 0
Free cash flow (dilution adjusted): 1667999.2492492492
Operating income: 2079648.3983983984
Net income: 1904717.2172172172
Long score: 8 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7902.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3925777408 (Mid Cap ($2B-$10B))
P/E ratio: 0.07890369767833041
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9830.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 155420753920 (Large Cap ($10B-$200B))
P/E ratio: 0.057988994848142184
Debt to equity: 0.5568
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9890.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5211695104 (Mid Cap ($2B-$10B))
P/E ratio: 0.6876407713674024
Debt to equity: 0.3282
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9890.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13456734208 (Large Cap ($10B-$200B))
P/E ratio: 0.05115311897163472
Debt to equity: 0.2566
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9913.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27789692928 (Large Cap ($10B-$200B))
P/E ratio: 0.15544469051809998
Debt to equity: 0.2854
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 9972.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3841654016 (Mid Cap ($2B-$10B))
Debt to equity: 0.41979999999999995
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ABR.V (quarterly, report date 2026-04-30)
Altman Z-score: 742.0975122731388 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.639427455473006%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.783859384319039%
Rule of 40 score: 0
Market cap: 14680994 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1311879.5620437956
Operating income: -205589.7810218978
Net income: -96110.94890510949
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for ADN.AX (annual, report date 2024-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.997470207346739%
Capitalized R&D asset: 1999541.0608358076
ROCI (R&D adjusted): -5.983341564120168%
Rule of 40 score: 0
Market cap: 32365420 (Nano Cap (< $50M))
Debt to equity: 0.0037
Free cash flow (dilution adjusted): -8631879.333333334
Operating income: -5860164.666666667
Net income: -4846104
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AEC (quarterly, report date 2026-03-31)
Altman Z-score: -0.09715998516620017 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.765054702580066%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.428192039983564%
Rule of 40 score: 0
Market cap: 80780944 (Micro Cap ($50M-$300M))
Debt to equity: 0.2354
Free cash flow (dilution adjusted): -5400807.194244605
Operating income: -4901243.165467626
Net income: -5069546.043165468
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AGLX.OL (annual, report date 2025-12-31)
Altman Z-score: 17.05863348607371 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -737.066199867314%
Capitalized R&D asset: 3878585.51
ROCI (R&D adjusted): -14.033633746798643%
Rosenberg metric: -0.7647927726315632
Free cash flow margin: -724.106790720652%
Revenue growth: 20.272268231840947%
Rule of 40 score: -703.8345224888111
Market cap: 2384924928 (Mid Cap ($2B-$10B))
Debt to equity: 3.3294
Free cash flow (dilution adjusted): -8794458
Operating income: -13307473
Net income: -148016502
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AGLX.OL (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2384924928 (Mid Cap ($2B-$10B))
Debt to equity: 3.3294
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AMCO.V (quarterly, report date 2026-03-31)
Altman Z-score: 4.721077467354977 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -75.14708144553414%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -81.53868345405276%
Rule of 40 score: 0
Market cap: 5822746 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -551133.8129496403
Operating income: -683214.3884892086
Net income: -690684.892086331
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for ASA (annual, report date 2025-11-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 60.37579930253643%
Capitalized R&D asset: 0
Revenue growth: 465.050204706724%
Rule of 40 score: 465.050204706724
Market cap: 948228160 (Small Cap ($300M-$2B))
P/E ratio: 1.4973003694231315
Debt to equity: 0
Net income: 664073428
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ASA (quarterly, report date 2025-11-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 948228160 (Small Cap ($300M-$2B))
P/E ratio: 1.4973003694231315
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BRW.V (quarterly, report date 2026-03-31)
Altman Z-score: 21.654213160893914 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.351925624362133%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.3689287943271076%
Rule of 40 score: 0
Market cap: 38122940 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1355739.568345324
Operating income: -698856.1151079137
Net income: -684297.1223021583
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CANFINHOME.NS (annual, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 18.34339535959977%
Capitalized R&D asset: 0
Free cash flow margin: -181.39591377953104%
Revenue growth: 9.277645577597085%
Rule of 40 score: -172.11826820193397
Market cap: 111456657408 (Large Cap ($10B-$200B))
P/E ratio: 0.10154465295668733
Debt to equity: 6.370900000000001
Free cash flow (dilution adjusted): -316538830.01271725
Net income: 115064889.7838067
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CANFINHOME.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -1.3664798464993375%
Rule of 40 score: -1.3664798464993375
Market cap: 108374523904 (Large Cap ($10B-$200B))
P/E ratio: 0.10698656954582915
Debt to equity: 6.3659
Net income: 28254130.182508703
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CAPS (quarterly, report date 2026-03-31)
Altman Z-score: -5.5612763619798775 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.676475049294707%
Free cash flow margin: -22.06734534064213%
Revenue growth: 0.06268609935746748%
Rule of 40 score: -22.004659241284664
Market cap: 3502811 (Nano Cap (< $50M))
Debt to equity: 2.7531
Free cash flow (dilution adjusted): -2818000
Operating income: -1497000
Net income: -1915000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CEMX.TO (quarterly, report date 2026-03-31)
Altman Z-score: 6.1389644996101405 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.3765670488978667%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.6033325619069654%
Free cash flow margin: 55.15584237264862%
Revenue growth: -42.66148547732625%
Rule of 40 score: 12.494356895322369
Market cap: 76391552 (Micro Cap ($50M-$300M))
P/E ratio: 16.54676258992806
Debt to equity: 0.0793
Free cash flow (dilution adjusted): 2889928.0575539568
Operating income: -1120143.8848920865
Net income: -833812.9496402878
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CHG.L (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1613840384 (Small Cap ($300M-$2B))
P/E ratio: 0.4149443561208267
Debt to equity: 0.5132
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CIZ.L (annual, report date 2025-12-31)
Altman Z-score: -63.07752998430141 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 583996.1212795074
ROCI (R&D adjusted): -767.7035595014703%
Rule of 40 score: 0
Market cap: 8711745 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -700000
Operating income: -987837.8378378379
Net income: -933783.7837837838
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for CIZ.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8711745 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTAS (annual, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 82394275840 (Large Cap ($10B-$200B))
P/E ratio: 34.95102040816326
Debt to equity: 0.5265
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTAS (quarterly, report date 2026-05-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 82394275840 (Large Cap ($10B-$200B))
P/E ratio: 34.95102040816326
Debt to equity: 0.5265
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DRUG (quarterly, report date 2026-03-31)
Altman Z-score: 110.3007601668246 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.3837046572453593%
Capitalized R&D asset: 18419119.83
ROCI (R&D adjusted): -3.0899318846014943%
Rule of 40 score: 0
Market cap: 699894336 (Small Cap ($300M-$2B))
Debt to equity: 0.0003
Free cash flow (dilution adjusted): -10451072
Operating income: -15319423
Net income: -10459627
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EL8.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 107172672 (Micro Cap ($50M-$300M))
Debt to equity: 0.0089
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FDI.V (quarterly, report date 2026-03-31)
Altman Z-score: 12.415238066443036 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.0068769088769958%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0068769088769958%
Free cash flow margin: 5.918389082362279%
Revenue growth: -79.21265681227622%
Rule of 40 score: -73.29426772991394
Market cap: 10313079 (Nano Cap (< $50M))
P/E ratio: 14.088443493655946
Debt to equity: 0
Free cash flow (dilution adjusted): 29184.172661870507
Operating income: 138973.38129496403
Net income: 138973.38129496403
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FRMI (quarterly, report date 2026-03-31)
Altman Z-score: 3.4583181074621416 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -58.742377202905594%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.802998825760996%
Rule of 40 score: 0
Market cap: 4721816576 (Mid Cap ($2B-$10B))
Debt to equity: 0.4337
Free cash flow (dilution adjusted): -582513000
Operating income: -166244000
Net income: -188693000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for FSV.TO (quarterly, report date 2026-06-30)
Altman Z-score: 2.607092196359801 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.928524260865095%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.005097622752716%
Free cash flow margin: 6.800658551159848%
Revenue growth: 7.709225834558055%
Rule of 40 score: 14.509884385717903
Market cap: 8911264768 (Mid Cap ($2B-$10B))
P/E ratio: 28.518298546297867
Debt to equity: 0.9037000000000001
Free cash flow (dilution adjusted): 69407042.25352113
Operating income: 72974647.88732395
Net income: 42908450.704225354
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for HGTY (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.205867082035304%
Capitalized R&D asset: 0
Free cash flow margin: 1.258377962351281%
Revenue growth: -19.652772588720005%
Rule of 40 score: -18.394394626368722
Market cap: 4010379520 (Mid Cap ($2B-$10B))
P/E ratio: 43.875
Debt to equity: 0.32049999999999995
Free cash flow (dilution adjusted): 3924000
Net income: -4491000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HURC (quarterly, report date 2026-04-30)
Altman Z-score: 2.932089016363385 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.0272196841927155%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3896401558560623%
Free cash flow margin: 1.963543197950355%
Revenue growth: 11.080526266679108%
Rule of 40 score: 13.044069464629462
Market cap: 137362784 (Micro Cap ($50M-$300M))
Debt to equity: 0.0558
Free cash flow (dilution adjusted): 935000
Operating income: -799000
Net income: -2372000
Long score: 7 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for INHD (quarterly, report date 2026-03-31)
Altman Z-score: 2624.4220819762477 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.2993355169616687%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.6892447263474146%
Free cash flow margin: -316.2700086167027%
Revenue growth: -36.505932582627274%
Rule of 40 score: -352.77594119932996
Market cap: 178522368 (Micro Cap ($50M-$300M))
Debt to equity: 0.0038
Free cash flow (dilution adjusted): -375938.13775510207
Operating income: -101002.04081632654
Net income: -137298.5969387755
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for LBGJ (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 103774 (Nano Cap (< $50M))
Debt to equity: 1.3635
Long score: 0 | Short score: 2
Recommendation: Neutral